Autoimmune Encephalitis primary prevention
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Julinka Auta Fernandes
|
Autoimmune Encephalitis Microchapters |
|
Differentiating Autoimmune Encephalitis from Other Conditions |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Autoimmune Encephalitis On the Web |
Overview
Autoimmune encephalitis has no established disease-specific strategy that reliably prevents a first episode. Primary prevention concerns preventing disease before it develops; treatment of established encephalitis and prevention of relapse are separate issues. Expert information from Mayo Clinic emphasizes that consistent preventive measures for autoimmune causes of encephalitis remain unavailable.[1]
Primary Prevention
Vaccination
Autoimmune encephalitis has no specific preventive vaccine. Vaccines against selected infections can prevent some infectious causes of encephalitis, but should not be described as proven prevention of autoimmune encephalitis.[1]
Autoimmune encephalitis patients who require immunosuppression may need vaccination review to reduce treatment-associated infection risk. This is a treatment-safety measure rather than prevention of a first autoimmune episode.[2]
Cancer Risk Assessment
Autoimmune encephalitis may be triggered by an associated neoplasm. Mayo Clinic advises discussing individual cancer risk and appropriate screening, because finding and treating a tumor early could potentially prevent some tumor-associated cases. This possibility should not be presented as a proven preventive strategy for all autoimmune encephalitis.[3]
Autoimmune encephalitis guidelines recommend targeted neoplasm investigation once the illness is suspected or diagnosed. This diagnostic workup is distinct from routine population cancer screening and does not establish a need for whole-body imaging in healthy people solely to prevent autoimmune encephalitis.[2]
See screening for an associated neoplasm.
Preventive Medication
Autoimmune encephalitis guidelines describe immunotherapy for patients with a supported clinical diagnosis. They do not establish a prophylactic immunotherapy regimen for otherwise unaffected individuals.[2]
Distinction from Secondary Prevention
Autoimmune encephalitis relapse prevention may involve follow-up and selected maintenance immunotherapy after an initial episode. These measures belong to secondary prevention rather than primary prevention; the need for ongoing treatment varies by subtype and clinical course.[4]
See secondary prevention and medical therapy.
References
- ↑ 1.0 1.1 Mayo Clinic News Network. Types of encephalitis: A Mayo Clinic expert explains.
- ↑ 2.0 2.1 2.2 Hahn C, Budhram A, Alikhani K, et al. Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in Adults. Can J Neurol Sci. 2024;51(6):734–754. doi:10.1017/cjn.2024.16. PMID:38312020.
- ↑ Mayo Clinic. Autoimmune encephalitis: Symptoms and causes.
- ↑ Abboud H, Probasco J, Irani SR, et al. Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management. J Neurol Neurosurg Psychiatry. 2021;92(8):897–907. doi:10.1136/jnnp-2020-325302. PMID:33649021.